Cost-Effectiveness of Betrixaban Compared with Enoxaparin for Venous Thromboembolism Prophylaxis in Nonsurgical Patients with Acute Medical Illness in the United States. pharmacoeconomics • December 24, 2018
A review of the economics of treating Clostridium difficile infection. pharmacoeconomics • April 10, 2015
Impacts of health insurance benefit design on percutaneous coronary intervention use and inpatient costs among patients with acute myocardial infarction in Shanghai, China. pharmacoeconomics • April 8, 2015
Treatment, monitoring, and economic outcomes of venous thromboembolism among hospitalized patients in China. pharmacoeconomics • April 8, 2015